21 September 2026 TGA pulls herbal ingredient over anaphylaxis risk 5 minute read Complementary Public Health Respiratory TGA By Amanda Sheppeard Andrographis will no longer qualify for Australia’s low-risk listed medicines pathway after continuing reports of severe allergic reactions and a fatal case. This content is for AHPRA registered professionals only.LoginJoin Now Previous Post Next Post
